Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Neoplasms of the CNS

Free Subscription 02.02.2026 1 Am J Clin Oncol 1 Childs Nerv Syst 2 Clin Cancer Res 5 J Neurooncol 5 Neuro Oncol 2 Neuroradiology 1 Neurosurgery 1 PLoS One 1 Pol J Radiol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. PARK S, Coven SL, Tran YH, Mendonca EA, et al
   Examining the Impact of Social Determinants of Health on Pediatric Central Nervous System Tumor Outcomes Through Medical Record Linkage.
   Am J Clin Oncol. 2026;49:82-88.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

2. SEATON MP, Ghauri MS, Forseth KJ, Schmidt JC, et al
   MRI-guided laser ablation for pediatric intracranial pathology: single center experience.
   Childs Nerv Syst. 2026;42:44.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

3. ENE CI, Singh S, Venkataraman T, Phillips LM, et al
   Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).
   Clin Cancer Res. 2026 Jan 29. doi: 10.1158/1078-0432.CCR-25-3566.
   PubMed         Abstract available
   
   
4. QU S, Pan Q, Zhang X, Wang J, et al
   Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification.
   Clin Cancer Res. 2026 Jan 26. doi: 10.1158/1078-0432.CCR-25-2496.
   PubMed         Abstract available
   
   

   
   J Neurooncol

5. DIPASQUALE A, Giordano P, Bosio A, Wijnenga MMJ, et al
   Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.
   J Neurooncol. 2026;176:186.
   PubMed        
   
   
6. GORWOOD W, Peciu-Florianu L, Strachowski O, Vannod-Michel Q, et al
   The neuropsychological outcome of patients undergoing intraoperative MRI surgery for insular infiltrating gliomas.
   J Neurooncol. 2026;176:187.
   PubMed         Abstract available
   
   
7. DIXIT KS, Kumthekar P, Lukas RV, Williams A, et al
   A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.
   J Neurooncol. 2026;176:185.
   PubMed        
   
   
8. LOPES TLM, Balsells MD, Cavalcante MA, de Queiroz AGD, et al
   Awake surgery versus general anesthesia in the treatment of Diffuse Low-Grade Gliomas - and the role of supplementary intraoperative techniques: a systematic review and meta-analysis.
   J Neurooncol. 2026;176:184.
   PubMed        
   
   
9. NOZZOLI F, Ortenzi V, Nucci E, Morelli I, et al
   Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study.
   J Neurooncol. 2026;176:183.
   PubMed        
   
   

   
   Neuro Oncol

10. SLEURS C, Zegers CML, Ribeiro MF, van Elmpt W, et al
    Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach.
    Neuro Oncol. 2025;27:2634-2646.
    PubMed         Abstract available
    
    
11. DUAN T, Taori S, Bhargava S, Lai S, et al
    Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cells.
    Neuro Oncol. 2025;27:2530-2546.
    PubMed         Abstract available
    
    
12. GERSTL JVE, Price M, Bernstock JD, Kruchko C, et al
    Years of life lost due to central nervous system tumor subtypes in the United States.
    Neuro Oncol. 2025;27:2738-2746.
    PubMed         Abstract available
    
    
13. NOZZOLI F, Rahmanzade R, Schmid S, Schweizer L, et al
    Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?
    Neuro Oncol. 2025;27:2711-2725.
    PubMed         Abstract available
    
    
14. SLATER JM, Horick NK, Nachtigall LB, Parsons MW, et al
    Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II study.
    Neuro Oncol. 2026 Jan 25:noag008. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

15. SINGH KPB, Lee MD, Young MG, Orringer D, et al
    MRI-based prediction of DNA methylation grade in IDH-mutant astrocytomas using qualitative imaging features and tumor volumetrics.
    Neuroradiology. 2025 Nov 11. doi: 10.1007/s00234-025-03766.
    PubMed         Abstract available
    
    
16. YAMASHITA K, Tomiyasu M, Kikuchi K, Momosaka D, et al
    The diagnostic value of cortical high-flow sign combined with cystathionine on (1)H-MRS for prediction of 1p/19q-codeletion status in IDH-mutant adult-type diffuse glioma.
    Neuroradiology. 2026 Jan 24. doi: 10.1007/s00234-026-03909.
    PubMed         Abstract available
    
    

    
    Neurosurgery

17. BUENO A, Dono A, Amezquita-Contreras C, Khalaj K, et al
    Molecular Features of Glioblastoma Isocitrate Dehydrogenase-Wildtype in Extreme Survival Groups After Supramaximal and Maximal Resection.
    Neurosurgery. 2026 Jan 27. doi: 10.1227/neu.0000000000003929.
    PubMed         Abstract available
    
    

    
    PLoS One

18. HOLMGREN AG, Malmstrom A, Degsell E, Simmons J, et al
    "My safe haven turned into a terror zone": A qualitative study of family members' experiences of violence by brain tumor patients.
    PLoS One. 2026;21:e0340959.
    PubMed         Abstract available
    
    

    
    Pol J Radiol

19. JAYANNA D, Kankara SR, K SR, Josephine A, et al
    Assessing glymphatic dysfunction using the diffusion tensor image analysis along the perivascular space (DTI-ALPS) index in gliomas and metastases.
    Pol J Radiol. 2025;90:e611-e620.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.